菌体治疗和血液恶性瘤中的微生物组:机会,机制和早期证据
Juanwen Zhang1, Jin Liu2, Alireza Bayani3
1Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia, 119991.
Journal of cancer research and clinical oncology
|December 12, 2025
概括
菌体疗法显示出通过向肠道微生物组失生症来治疗血液癌症的前景. 菌体可能增强抗瘤免疫力,克服耐药性,尽管临床证据仍在出现.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 由于异质性,免疫功能障碍和耐药性,血液恶性瘤难以治疗.
- 肠道微生物组失调严重影响癌症治疗的治疗结果.
- 菌体 (菌体) 提供了一种精确的方法来调节微生物群.
研究的目的:
- 探索菌体治疗作为血液恶性瘤的辅助治疗的潜力.
- 审查菌体影响肠道微生物群和抗瘤免疫力的机制.
- 确定血液癌症治疗中菌体治疗的挑战和未来方向.
主要方法:
- 对癌症菌体治疗的临床前和早期人类研究的综述.
- 对影响微生物生态系统和宿主免疫力的菌体机制的分析.
- 对工程菌体应用和转化障碍的讨论.
主要成果:
- 菌体可以选择性地消除病原体,保存有益的细菌,并增强抗瘤免疫反应.
- 菌体DNA激活免疫通路,可能改善细胞毒性T淋巴细胞活性.
- 工程菌体显示了基因编辑和向白血病治疗的潜力.
结论:
- 菌体疗法是一个有前途的微生物组知情策略,用于打击血液性恶性瘤中抗药性.
- 解决免疫性和监管问题等挑战对于临床翻译至关重要.
- 需要进一步的临床试验来确定菌体治疗在血液癌症中的疗效.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
914
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
914
01:30Lytic Cycle of Bacteriophages
77.3K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.3K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K